Infectious Disease
Oragenics secures CQDM funding for Covid-19 vaccine antigen development
Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its…
Pneumagen raises £8 million for further study of intranasal antiviral
Pneumagen has raised £8m ($10 million) for the further development of its intranasal antiviral drug neumifil in Phase II studies…
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine,…
Valneva seeks Health Canada approval for chikungunya vaccine
Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553. The vaccine…
Roche Canada and pCPA conclude talks for Vabysmo eye therapy
Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Vabysmo is administered into…
Meningitis vaccine comes to the forefront with impressive study results
A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa.…
Clover collaborates with Kyuan Trade to launch AdimFlu-S (QIS) in China
Clover Biopharmaceuticals has established a commercial collaboration with Keyuan Xinhai (Beijing) Medical Products Trading (Kyuan Trade) for the launch of…
FDA approves breakthrough pneumonia therapy
Innoviva has snagged a win for its bacterial pneumonia drug Xacduro (durlobactam sodium + sulbactam) with a US Food and…
Croda Pharma and BSI partner for vaccine adjuvant QS-21 production
Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade…
Parliamentarians call on G7 leaders to invest in neglected tropical diseases
Parliamentarians from 24 countries worldwide have called for a renewed commitment and increased investment for neglected tropical diseases or NTDs,…